Although there are many factors and regulators that affect myocardial hypertrophy, the renin-angiotensin (RAS) and its primary effector peptide, AngII, are involved in the pathophysiology of cardiac hypertrophy and failure. Here, AGT is linked to cardiac hypertrophy.